Publication | Closed Access

ATB-346, a novel hydrogen sulfide-releasing anti-inflammatory drug, induces apoptosis of human melanoma cells and inhibits melanoma development in vivo

InflammationAnti-inflammatoryMedicineApoptosisImmunologyHuman Melanoma CellsCell DeathAnti-cancer AgentPharmacologyTumor BiologyOxidative Stress